Advertisement

Topics

AbbVie pays CytomX $15M for cancer Probody-drug conjugate milestones

04:11 EDT 3 Jul 2017 | SmartBrief

AbbVie will give CytomX Therapeutics a $15 million milestone payment for advancing a cancer-fighting Probody-drug conjugate,  -More

Original Article: AbbVie pays CytomX $15M for cancer Probody-drug conjugate milestones

NEXT ARTICLE

More From BioPortfolio on "AbbVie pays CytomX $15M for cancer Probody-drug conjugate milestones"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...